Final Report: A Phase 3, Randomized, Placebo- Controlled, Observer-Blinded Trial to Evaluate the Safety of a 6-Valent OspA-Based Lyme Disease Vaccine (LB6V) in Healthy Children 5 Through 17 Years of Age

Final Report: A Phase 3, Randomized, Placebo- Controlled, Observer-Blinded Trial to Evaluate the Safety of a 6-Valent OspA-Based Lyme Disease Vaccine (LB6V) in Healthy Children 5 Through 17 Years of Age chavak11 Tue, 04/28/2026 - 09:09 PF-07307405 PF-07307405 PHASE III Mon, 12/12/2022 - 12:00 Mon, 07/21/2025 - 12:00 NCT05634811 C4601012 Public Disclosure Synopsis .pdf (104.22 KB) N https://clinicaltrials.gov/study/NCT05634811?term=%20C4601012&viewType=Card&rank=1 C4601012